Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
The field of antibody drug conjugates has seen many ups and downs, but with new science shedding light on how to better design and engineer these therapies, it’s certainly never boring. We look at the latest happenings reshaping this dynamic space.
Though mRNA technologies are helping to expand the industry's horizons, there manufacture does come with challenges.
Applying mRNA technology to the treatment of malaria.
Could mRNA vaccine be the flu interventions of tomorrow?
We sit down with CureVac's Igor Splawski, who discusses the achievements that could define the next chapter of the mRNA success story.
Defining the best strategies for working with highly potent drug substances.
Embracing the benefits of auto-injectors.
What milestones will define the next era in the mRNA story?
Welcome to our Special Series E-book on Advanced Medicine!
Manufacturers must look to ease the headaches associated with the manufacture of mRNA-based products.
Swiss firm Lonza is taking its investment in China to the next level with a manufacturing upgrade to its key site in Guangdong Province.
What are the challenges and best practices in quality control for difficult-to-inspect products?
Has pharma fully acknowledged the power of rapid-dissolve tablet technologies?
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
A Breath of Fresh Air
Of Medicine and Machine Learning
A Nice Cup of RDT